联系我们

论文查询结果	返回搜索

论文编号：	16033
作者编号：	2320233759
上传时间：	2026/6/3 13:50:24
中文题目：	A公司高血压药吲达帕胺缓释片营销策略优化研究
英文题目：	Research on the Optimization of MarketingStrategy for Company A''''s AntihypertensiveDrug Indapamide Sustained-ReleaseTablets
指导老师：	马连福
中文关键字：	医药改革；吲达帕胺缓释片；营销策略优化；7Ps营销理论；制药企业
英文关键字：	Pharmaceutical reform; Marketing strategy optimization; 7Ps marketing theory；Indapamide
中文摘要：	在国家医药改革不断深入的背景下，随着以一致性评价为基础的国家带量采购常态化实施（目前已开展至第11批，涵盖约500个品种），以及药品价格管控政策的全面落地，包括“四同、三同、二同”政策和专家挂网共识政策等，医药行业当前正遇到前所未有的转型挑战。这一政策环境倒逼医药企业从高速增长模式转向高质量发展道路，药物研发的创新性需求日益增强。在此背景下，新产品的成功上市将成为企业实现可持续发展的重要驱动力。 本研究以A公司战略产品吲达帕胺缓释片为研究对象。作为2024年上市的重点新品，该产品目前面临多重营销挑战：其一，由于原研厂家市场培育不足，产品仍处于市场导入期，医疗机构认知度和处方意愿较低；其二，现有营销策略存在系统性缺陷，主要体现在：缺乏权威循证医学证据支持、产品定价竞争力不足、渠道建设滞后且分布不均、推广手段单一低效、营销团队专业化水平欠缺、产品包装视觉吸引力不足、销售流程冗长低效等。针对这些问题，系统优化吲达帕胺缓释片的营销策略具有重要的现实意义和战略价值。 本研究聚焦A公司吲达帕胺缓释片的市场营销策略，基于7PS理论框架，本文综合运用文献研究、案例分析、问卷调查及深度访谈等多种方法，通过系统分析该产品现有营销策略的问题及成因，结合STP理论和SWOT分析工具，最终提出了涵盖产品、价格、渠道、促销、人员、有形展示和服务流程等七个维度的优化方案。研究中要重点优化符合临床需求的产品策略、建立动态定价机制、完善渠道合作体系、创新新媒体营销方式、提升团队专业服务能力、强化产品差异化展示以及构建慢病管理服务体系，并制定了相应的实施保障策略。 该研究成果不仅能够帮助A公司显著提升吲达帕胺缓释片的市场竞争力和销售业绩，实现预期的营销目标，同时也为医药行业同类产品的市场推广提供了可资借鉴的实践经验和策略思路，对于推动医药企业的营销模式转型与升级，具有重要的参考意义。
英文摘要：	Against the backdrop of deepening national healthcare reforms, with the regular implementation of volume-based procurement (VBP) based on consistency evaluation (currently in its 11th round, covering approximately 500 varieties) and the full enforcement of drug price control policies—including the "Four Sameness, Three Sameness, Two Sameness" policies and the expert consensus pricing policy—the pharmaceutical industry is undergoing unprecedented transformation challenges. This policy environment is forcing pharmaceutical companies to shift from a high-speed growth model to a high-quality development path, with an increasing demand for innovation in drug R&D. In this context, the successful launch of new products will become a key driver for enterprises to achieve sustainable development. This study focuses on Company A's strategic product, indapamide sustained-release tablets. As a key new product launched in 2024, it currently faces multiple marketing challenges: First, due to insufficient market cultivation by the originator company, the product remains in the market introduction phase, with low awareness and prescription willingness among medical institutions. Second, the existing marketing strategy suffers from systematic deficiencies, including: a lack of authoritative evidence-based medical support, insufficient pricing competitiveness, lagging and uneven channel development, monotonous and inefficient promotional methods, a lack of professionalism in the marketing team, unappealing product packaging, and lengthy, inefficient sales processes. Addressing these issues and systematically optimizing the marketing strategy for indapamide sustained-release tablets holds significant practical and strategic value. This research centers on the marketing strategy of Company A's indapamide sustained-release tablets. Based on the 7PS theoretical framework, the study employs a combination of literature review, case analysis, questionnaire surveys, and in-depth interviews. Through a systematic analysis of the problems and root causes of the current marketing strategy, along with STP repositioning and SWOT analysis tools, the study ultimately proposes an optimized plan covering seven dimensions: product, price, place, promotion, people, physical evidence, and process. Key focus areas include refining the product strategy to align with clinical needs, establishing a dynamic pricing mechanism, improving channel collaboration systems, innovating new media marketing approaches, enhancing the team's professional service capabilities, strengthening differentiated product presentation, and building a chronic disease management service system. Corresponding implementation safeguards are also outlined. The findings of this study will not only help Company A significantly enhance the market competitiveness and sales performance of indapamide sustained-release tablets, achieving its intended marketing goals, but also provide valuable practical insights and strategic references for the promotion of similar pharmaceutical products. It holds important implications for driving the transformation and upgrading of marketing models in the pharmaceutical industry.
查看全文：	预览  下载(下载需要进行登录)